RAB5A and Alzheimer disease: In multiple cell types from AD patients or mouse AD models, endocytic activation associated with increased RAB5 activity led to late endosomal dysfunction [8,9], which suggests that increased RAB5 activity could in turn lead to elevated RAB7 expression.